Stem cell-based retinal implant shows promising results for advanced dry AMD

A first-of-its-kind stem cell-based retinal implant for patients with advanced dry age-related macular degeneration was well-tolerated and showed promising early efficacy in a phase 1/2a study.

Researchers evaluated the use of human embryonic stem cells implanted in patients with advanced dry AMD. The study evaluated the primary safety of the treatment and noted any restoration of vision or prevention of vision loss in a patient cohort, lead author Amir H. Kashani, MD, PhD, assistant professor of clinical ophthalmology at the Keck School of Medicine of USC, told Healio.com/OSN.